Compared with adjacent tissues, the high or low expression of GATA4 in cancer tissues accounted for 23.1% and 76.9%, 16.7% and 83.3% in HBV-HCC patients and in non-HBV-HCC patients, respectively. The gene discussed is GATA4; the disease is cancer.